Proposed LCD DL40278: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer — WPS
Policy LCD-DL40278 · Oncology
New LCD may impact billing for cancer genomic tests.
Code intelligence
C92.61 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code C92.61.
Elevated code riskView ICD-10 detail
Signal breakdown
1 shown · 1 total in platform
Risk: Elevated
0
Critical
0%
1
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
Audit documentation
Building an audit file that includes C92.61?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription